Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937

Glycobiology

Volumn 20, Issue 3, 2009, Pages 395-402

  Mitsuki, Motoaki ^a,c   Nara, Kiyomitsu ^e,f   Yamaji, Toshiyuki ^b,c   Enomoto, Ayako ^c   Kanno, Mayumi ^e,f   Yamaguchi, Yoshiki ^d   Yamada, Akane ^f   Waguri, Satoshi ^f   Hashimoto, Yasuhiro ^c,e,f  

^a PHARMACEUTICALS AND MEDICAL DEVICES AGENCY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c Supra Biomolecule Research Group   (Japan)

^d Japan Science and Technology Agency   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^f FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell death; Monocytes; Natural killer cells; Siglec

Indexed keywords

ACETYLCYSTEINE; CASPASE 3; LECTIN; SIGLEC 7 PROTEIN; SIGLEC 9 PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL DEATH; CELL STRAIN U937; CHIMERA; COMPUTER MODEL; CONTROLLED STUDY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; ANTIBODIES, MONOCLONAL; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DEATH; HUMANS; LECTINS; MONOCYTES; TYROSINE; U937 CELLS;

EID: 77949907275     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwp195     Document Type: Article

References (31)

1. Angata T, Tabuchi Y, Nakamura K and Nakamura M. 2007. Siglec-15: An immune system Siglec conserved throughout vertebrate evolution. Glycobiology. 17(8):838-846.
2. Balaian L, Ball ED. 2001. Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling inmyeloid cells. Leuk Res. 25(12):1115-1125.
3. Balaian L, Ball ED. 2004. Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 x anti-CD64 antibodies. Leuk Res. 28(8):821-829.
4. Balaian L, Ball ED. 2005. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways. Exp Hematol. 33(2):199-211.
5. Balaian L, Zhong RK, Ball ED. 2003. The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression. Exp Hematol. 31(5):363-371.
6. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M. 2006. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood. 107(6):2474-2476.
7. BlasiusAL, Colonna M. 2006. Sampling and signaling in plasmacytoid dendritic cells: The potential roles of Siglec-H. Trends Immunol. 27(6):255-260.
8. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol. 7(4):255-266.
9. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, Pieper U, Sali A. 2006. Comparative protein structure modeling using Modeller. Current Protocols in Bioinformatics. Chapter 5 (Unit 5.6).
10. Falco M, Biassoni R, Bottino C, Vitale M, Sivori S, Augugliaro R, Moretta L, Moretta A. 1999. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J Exp Med. 190(6):793-802.
11. Fiser A, Do RK, Sali A. 2000. Modeling of loops in protein structures. Protein Sci. 9(9):1753-1773.
12. Freeman S, Birrell HC, D'Alessio K, Erickson-Miller C, Kikly K, Camilleri P. 2001. A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition. Eur J Biochem. 268(5):1228-1237.
13. Kasahara K, Watanabe Y, Yamamoto T, Sanai Y. 1997. Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae-like domains. J Biol Chem. 272(47):29947-29953.
14. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J Appl Crystallogr. 26: 283-291.
15. Marti-Renom MA, Stuart AC, Fiser A, Sanchez R, Melo F, Sali A. 2000. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct. 29: 291-325.
16. Miyazaki K, Ohmori K, Izawa M, Koike T, Kumamoto K, Furukawa K, Ando T, Kiso M, Yamaji T, Hashimoto Y, et al. 2004. Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers. Cancer Res. 64(13):4498-4505.
17. Nara K, Watanabe Y, Maruyama K, Kasahara K, Nagai Y, Sanai Y. 1994. Expression cloning of a CMP-NeuAc:NeuAc α2,3Galβ1,4Glcβ1,1′Cer α2,8-sialyltransferase (GD3 synthase) from human melanoma cells. Proc Natl Acad Sci USA. 91: 7952-7956.
18. Nicoll G, Ni J, Liu D, Klenerman P, Munday J, Dubock S, Mattei MG, Crocker PR. 1999. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J Biol Chem. 274(48):34089-34095.
19. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108(2):193-199.
20. Nutku E, Aizawa H, Hudson SA, Bochner BS. 2003. Ligation of Siglec-8: A selective mechanism for induction of human eosinophil apoptosis. Blood. 101(12):5014-5020.
21. Pearson WR. 1991. Searching protein sequence libraries: Comparison of the sensitivity and selectivity of the Smith-Waterman and FASTA algorithms. Genomics. 11(3):635-650.
22. Sali A, Blundell TL. 1993. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 234(3):779-815.
23. Sentman CL, Barber MA, Barber A, Zhang T. 2006. NK cell receptors as tools in cancer immunotherapy. Adv Cancer Res. 95: 249-292.
24. Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature. 387(6633):569-572.
25. Smith TF, Waterman MS. 1981. Identification of common molecular subsequences. J Mol Biol. 147(1):195-197.
26. Vitale C, Romagnani C, Falco M, Ponte M, Vitale M, Moretta A, Bacigalupo A, Moretta L, Mingari MC. 1999. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc Natl Acad Sci USA. 96(26):15091-15096.
27. von Gunten S, Schaub A, Vogel M, Stadler BM, Miescher S, Simon HU. 2006. Immunologic and functional evidence for anti-Siglec-9 autoantibodies in intravenous immunoglobulin preparations. Blood. 108(13):4255-4259.
28. von Gunten S, Yousefi S, Seitz M, Jakob SM, Schaffner T, Seger R, Takala J, Villiger PM, Simon HU. 2005. Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment. Blood. 106(4):1423-1431.
29. Waguri S, Kohmura M, Gotow T, Watanabe T, Ohsawa Y, Kominami E, Uchiyama Y. 1999. The induction of autophagic vacuoles and the unique endocytic compartments, C-shaped multivesicular bodies, in GH4C1 cells after treatment with 17beta-estradiol, insulin and EGF. Arch Histol Cytol. 62(5):423-434.
30. Yamaji T, Mitsuki M, Teranishi T and Hashimoto Y. 2005. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: Attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs. Glycobiology. 15(7):667-676.
31. Yamaji T, Teranishi T, Alphey MS, Crocker PR, Hashimoto Y. 2002. A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9. J Biol Chem. 277(8):6324-6332.